Back to Top Skip to main content Skip to sub-navigation

Based on data, MHS experts encourage vaccines for adolescents

Sister and brother smiling at each other Lucy Yun, 12, and Eli Yun, 14, pose for a family photo in San Antonio, Texas, May 2, 2021. The siblings, along with their brother Theo, 17, and their mother, Air Force Col. Heather Yun, deputy commander for medical services and an infectious disease physician, participated in vaccine trials. The Food and Drug Administration recently expanded the emergency use authorization to include the Pfizer vaccine for adolescents 12 to 15 years old (Photo by: Air Force Col. Heather Yun).

Recommended Content:

COVID-19 Vaccine Toolkit | Coronavirus | COVID-19 Vaccine Efforts | Children's Health | Vaccine Eligibility

Air Force Col. Heather Yun enrolled her teenagers in COVID-19 vaccine trials in back in the winter.

An infectious disease physician, Yun spoke with her children at length about the vaccine studies, and they were eager to do their part in the battle against the pandemic. More nervous about the blood draw than the shot, her children "overcame their fears and got it done," she said.

"I am so incredibly proud of my brave kids for doing their part for their community and the nation," said Yun, who also serves as Brooke Army Medical Center's deputy commander of medical services.

With the recent authorization of the Pfizer vaccine for youth ages 12 to 15, Yun is now encouraging other parents to consider the vaccine for their adolescents as well.

"The data continues to demonstrate that the vaccine is safe and effective," Yun said. "Vaccinating this population is an important step in ending the pandemic."

LAYER OF PROTECTION

With emergency use authorization and a 100 percent efficacy rate for this age group, "we are strongly recommending the vaccine for adolescents," noted Army Maj. Megan Donahue, BAMC's chief, pediatric infectious diseases.

However, vaccine hesitancy continues to be an ongoing challenge, particularly among young people who feel less threatened by the virus due to lower infection rates and reports of mild illness, noted Air Force Lt. Col. Alice Barsoumian, associate professor of medicine, San Antonio Uniformed Services Health Education Consortium Infectious Disease Fellowship Program.

While it's true that fewer children have been infected with COVID than adults, experts are tracking an increase in COVID infection and hospitalizations within younger populations, Barsoumian said, citing reopening schools and the easing of face covering requirements as potential causes. Additionally, some strains appear to be more contagious to children.

"Thankfully, hospitalization rates are still low," she said, "But we need to keep in mind that one in three children hospitalized with COVID is admitted to the ICU (intensive care unit)."

Children may also be at risk of a severe inflammatory response to COVID infection called Multisystem Inflammatory Syndrome, or MIS-C, a condition where different body parts can become inflamed, including the heart, lungs, kidneys, brain, skin, eyes, or gastrointestinal organs, according to the Centers for Disease Control and Prevention. While a direct link to COVID-19 hasn’t been established, many children with MIS-C had the virus or had been around someone with the infection.

Another risk is post-acute COVID syndrome, which causes symptoms to include fatigue, exercise intolerance, depression and poor sleep, explained Army Lt. Col. Elizabeth Markelz, BAMC's chief of infectious disease service. “This syndrome does not occur with immunization," she noted.

Education and awareness remain key to boosting vaccination rates. "The vaccine is incredibly important for building herd immunity," Markelz said. "Additionally, children have the same transmissibility to others as adults, providing an important route of spread to their loved ones."

Yun's 12-year-old daughter, Lucy, agrees. "I think it's important for kids to get vaccinated because even though in some cases we're less likely to get hurt from sicknesses, it's better for protecting people who are higher risk," she said.

MINIMAL SIDE EFFECTS

The Pfizer vaccine is administered in the same dosage and dosing regimen for 12 to 15-year-olds as it is for ages 16 and older - which is two doses 21 days apart. The COVID-19 vaccine and other vaccines may be administered without regard to timing, according to new CDC guidance. Out of an abundance of caution, the CDC previously had recommended a minimum of 14 days between the COVID-19 vaccine and other vaccines; however, data has indicated the safety of simultaneous administration.

As with adults, adolescents are reporting varying non-serious side effects post-vaccination, typically lasting for one to three days, Barsoumian said. These side effects can include pain at the injection site, tiredness, headache, chills, muscle pain, fever and joint pain.

Yun's 14-year-old son, Eli, reported a few side effects after his shot. "The vaccine itself didn't actually hurt when it was injected, but afterward, I had a pretty sore arm following the first dose, and flu-like symptoms following the second dose for a few days," he said.

"Side effects appear similar, but occur slightly more frequently in this population than in older populations," Barsoumian said. "We've noticed this in the adult population as well – the somewhat younger you are, the somewhat more frequently they occur."

MOVING FORWARD

While Pfizer is currently the only FDA-approved vaccine for 12 to 15-year-olds, other manufacturers, such as Moderna, are likely to follow. As for the younger age groups, based on the study cohorts, the manufacturers will most likely roll out approval in stages, Barsoumian said, starting with 6- to 11-year-olds and followed by 2- to 5-year-olds at a later date.

Barsoumian is eager for that day to arrive. Her children, who are 10 and younger, are unable to get the shot at this time, but she has signed them up for all available studies across the state.

Markelz has also signed her young children up for local studies and is awaiting enrollment to open. "My kids dread getting vaccines, but they both have stated they will get it when they can because they want to protect 'nanna, papa and their teachers,'" she said.

With authorization at hand, many parents and adolescents are lining up to get the shot. The CDC has announced that half a million kids ages 12 to 15 have received a COVID-19 vaccine in less than one week and, in total, more than 4.1 million adolescents ages 12 to 17 have been vaccinated so far.

"This is incredible progress," Barsoumian said. "Go get ‘em kids!"

You also may be interested in...

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA PI 6025.16: Processes and Procedures for Implementation of Standardized Perinatal Training

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (p), establishes the Defense Health Agency’s (DHA) procedures to describe standard processes and criteria for developing and sustaining comprehensive systems to provide, assess, and monitor standardized perinatal training for military medical personnel providing services to mothers and infants.

  • Identification #: 6025.16
  • Date: 4/30/2019
  • Type: DHA Procedural Instruction
  • Topics: Children's Health
Showing results 1 - 11 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.